Answer
Arixtra (fondaparinux sodium) 2.5 mg/0.5 ml is indicated for preventing venous thromboembolic events in adults undergoing major lower-limb orthopaedic surgery, such as hip fracture surgery, major knee surgery or hip replacement surgery.
Sources for this answer
- Arixtra 2.5 mg/0.5 ml solution for injection, pre-filled syringeViatris (formerly Mylan or Upjohn) · emc · SmPC §4.1 Therapeutic Indications · Version 7Document updated
Sources checked